Search Results - "Nummy, Laurence J."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2
  3. 3

    Process Safety Evaluation of a Magnesium−Iodine Exchange Reaction by Reeves, Jonathan T, Sarvestani, Max, Song, Jinhua J, Tan, Zhulin, Nummy, Laurence J, Lee, Heewon, Yee, Nathan K, Senanayake, Chris H

    Published in Organic process research & development (17-11-2006)
    “…An unexpected highly exothermic decomposition was observed during routine safety analysis of the magnesium−iodine exchange reaction of 2-iodo-4-fluorotoluene…”
    Get full text
    Journal Article
  4. 4

    Practical Synthesis of an Enantiomerically Pure trans-4,5-Disubstituted 2-Pyrrolidinone via Enzymatic Resolution. Preparation of the LTB4 Inhibitor BIRZ-227 by Yee, Nathan K, Nummy, Laurence J, Byrne, Denis P, Smith, Lana L, Roth, Gregory P

    Published in Journal of organic chemistry (23-01-1998)
    “…A practical synthesis of the enantiomerically pure BIRZ-227 (1), a LTB4 inhibitor, has been developed. The key steps include the effective synthesis of the…”
    Get full text
    Journal Article
  5. 5

    Practical synthesis of a cell adhesion inhibitor by self-regeneration of stereocenters by Yee, Nathan K., Nummy, Laurence J., Frutos, Rogelio P., Song, Jinhua J., Napolitano, Elio, Byrne, Denis P., Jones, Paul-James, Farina, Vittorio

    Published in Tetrahedron: asymmetry (14-11-2003)
    “…An efficient enantiospecific synthesis of the cell adhesion inhibitor BIRT-377 by self-regeneration of stereocenters has been achieved in 38% overall yield in…”
    Get full text
    Journal Article
  6. 6

    Synthesis of five nevirapine metabolites by Grozinger, Karl G., Byrne, Denis P., Nummy, Laurence J., Ridges, Michael D., Salvagno, Annette

    Published in Journal of heterocyclic chemistry (01-03-2000)
    “…Nevirapine (1) is a non‐nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune® since 1996. In vitro studies…”
    Get full text
    Journal Article
  7. 7